Recipharm appoints new directors
pharmafile | May 1, 2014 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Henning Neubauer, Recipharm, lopez, wilander
Contract development and manufacturing organisation Recipharm has hired two new directors for its business management unit.
Henning Neubauer (pictured) takes on the position of business director for Northern Germany and the Netherlands. In parallel, Antonio Lopez also joins the team in the role of business director for Spain and Southern France.
Previously Neubauer was chief operating officer at a German start-up company in Hamburg dealing with generic products, OTC and Rx. Prior to that, he worked for more than 10 years at Haupt Pharma as head of customer service and sales.
Lopez has previous experiences in business development and partnering, logistics, compliance and regulatory activities in the role as VP of operations in Flavine, a US trading company involved in generics APIs and finished dosage forms. Prior to this, he worked for more than 20 years at the Spanish pharma firm Grupo Uriach.
Åsa Wilander joined the team in mid-January in the new role of key account director for the Nordic region. In this role, Wilander will be responsible for co-ordinating customer management and commercial aspects, as well as developing relationships with a selected number of customers.
Wilander has been with Recipharm since 2007. To date, she has been working as general manager of the Höganäs facility. She has some 30 years’ experience of the pharma industry including the leadership of a contract manufacturing supply team at Pfizer.
Kenth Berg, VP business management at Recipharm says: “I am very pleased to have such talent join our business management structure. Europe is one of our key markets and we look forward to utilising the respective skills and expertise of Henning and Antonio to further enhance our European sales drive in Germany, the Netherlands and Spain.”
Related Content
Recipharm offers manufacturing support to vaccine trial from ImmBIO and iiCON
Recipharm, a contract development and manufacturing organisation (CDMO), has successfully manufactured PnuBioVax, a new protein-based …
Recipharm designates Germany site as Centre of Excellence
The multi-product facility recently underwent significant renovations
Strategic alliance announced between Recipharm and Exela
Recipharm and Exela have announced that they have entered into an exclusive strategic alliance. The …
